Streetbeat News

Legal

EBS

JNJ

Johnson & Johnson (NYSE:JNJ) is set to release its Q2 earnings on July 17, with analysts expecting an EPS of $2.70 and revenue of $22.29 billion. The company offers a 3.32% annual dividend yield. Emergent BioSolutions (NYSE:EBS) has settled a dispute with J&J's Janssen Pharmaceuticals regarding COVID-19 vaccine manufacturing.

Portfolio Pulse from Avi Kapoor

July 16, 2024 | 12:06 pm

BA

ITA

PPA

A U.S. judge has set a rapid schedule for addressing objections from victims' families regarding Boeing's plea deal over the 737 MAX crashes. Boeing has agreed to plead guilty to criminal fraud conspiracy and pay a $243.6 million fine. The company will also spend $455 million over three years to enhance safety and compliance programs. Boeing stock has lost over 15% in the last 12 months.

Portfolio Pulse from Shivani Kumaresan

July 16, 2024 | 10:04 am

MASI

Masimo has initiated litigation against Politan Capital Management in a federal court in California. The lawsuit seeks to compel Politan to correct alleged material misstatements and omissions in its proxy materials.

Portfolio Pulse from Benzinga Newsdesk

July 16, 2024 | 9:24 am

AAPL

The U.S. Customs and Border Protection has ruled that the redesigned ECG in the Apple Watch does not infringe on AliveCor's patents, allowing Apple to import these models without additional costs. This decision is a setback for AliveCor in its ongoing legal battles against Apple.

Portfolio Pulse from Benzinga Neuro

July 16, 2024 | 6:25 am

VZ

Several major record labels have filed a $2.6 billion lawsuit against Verizon Communications Inc. (NYSE:VZ) for allegedly facilitating massive copyright infringement by its subscribers. The lawsuit claims Verizon ignored hundreds of thousands of infringement notices and continued to provide high-speed internet to known repeat infringers.

Portfolio Pulse from Benzinga Neuro

July 16, 2024 | 5:30 am

DJT

U.S. Secret Service Director Kimberly Cheatle has announced she will not resign following an assassination attempt on former President Donald Trump at a rally in Pennsylvania. The incident resulted in the death of a rally attendee and has led to intense scrutiny of the Secret Service. Cheatle has accepted responsibility and is committed to investigating the incident to prevent future occurrences.

Portfolio Pulse from Benzinga Neuro

July 16, 2024 | 1:00 am

SNDL

SNDL Inc (NASDAQ:SNDL) is employing an aggressive loan-to-own strategy to control distressed cannabis companies. By acquiring secured debt and pressuring companies into bankruptcy, SNDL gains ownership of their assets. Recent actions include acquiring $20.7 million of Delta 9's secured debt, increasing leverage over Delta 9. This strategy has been successful with other companies like Skymint and Parallel, positioning SNDL as a dominant force in the cannabis industry.

Portfolio Pulse from Javier Hasse

July 15, 2024 | 8:47 pm

MDWD

TEVA

MediWound has filed an amendment to its settlement agreement with Teva. Under the amendment, MediWound will prepay Teva $4 million as the final payment due under the agreement, with 50% of the prepayment in cash and 50% in the form of ordinary shares of MediWound.

Portfolio Pulse from Benzinga Newsdesk

July 15, 2024 | 8:13 pm

VRTX

Vertex Pharmaceuticals is seeking a federal court ruling to confirm that its financial support program for fertility services related to Casgevy does not violate federal anti-kickback laws. The company disagrees with the regulator's conclusion.

Portfolio Pulse from Benzinga Newsdesk

July 15, 2024 | 5:06 pm

VRTX

Vertex Pharmaceuticals has filed a lawsuit against the U.S. Department of Health and Human Services regarding its Casgevy gene editing therapy.

Portfolio Pulse from Benzinga Newsdesk

July 15, 2024 | 5:00 pm